Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 132  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 
Read this article

 


    Article Cited by others

DRUG REVIEW

Sildenafil in pediatric pulmonary arterial hypertension

Dhariwal A K, Bavdekar S B

Year : 2015| Volume: 61| Issue : 3 | Page no: 181-192

   This article has been cited by
 
1 Pediatric Population Pharmacokinetic Modeling and Exposure–Response Analysis of Ambrisentan in Pulmonary Arterial Hypertension and Comparison With Adult Data
Malek Okour, Mita M. Thapar, Colm Farrell, Mary Ann Lukas, Maurice Beghetti, Misba Beerahee
The Journal of Clinical Pharmacology. 2023;
[Pubmed]  [Google Scholar] [DOI]
2 Sildenafil Improves Pulmonary Vascular Remodeling in a Rat Model of Persistent Pulmonary Hypertension of the Newborn
Lili Kang, Xianghong Liu, Zilong Li, XiaoMei Li, Yujie Han, Chen Liu, Cuifen Zhao, Xiaoying Li
Journal of Cardiovascular Pharmacology. 2023; 81(3): 232
[Pubmed]  [Google Scholar] [DOI]
3 Efficacy and safety of endothelin receptor antagonists, phosphodiesterase type 5 Inhibitors, and prostaglandins in pediatric pulmonary arterial hypertension: A network meta-analysis
Fen Cao, Kun Wu, Yong-zhi Zhu, Jun-jun Jiang, Gui Zhang, Jun Liu, Ping Xiao, Yang Tian, Wei Zhang, Sheng Zhang, Feng Hou, Zhong-wu Bao
Frontiers in Cardiovascular Medicine. 2023; 9
[Pubmed]  [Google Scholar] [DOI]
4 Population pharmacokinetic analysis of sildenafil in term and preterm infants with pulmonary arterial hypertension
Su-jin Rhee, Seung Han Shin, Jaeseong Oh, Young Hwa Jung, Chang Won Choi, Han-Suk Kim, Kyung-Sang Yu
Scientific Reports. 2022; 12(1)
[Pubmed]  [Google Scholar] [DOI]
5 The role of inflammation in cadmium nephrotoxicity: NF-?B comes into view
Emad H.M. Hassanein, Wafaa R. Mohamed, Osama S. Ahmed, Mohamed M. Abdel-Daim, Ahmed M. Sayed
Life Sciences. 2022; : 120971
[Pubmed]  [Google Scholar] [DOI]
6 Patient-specific and gene-corrected induced pluripotent stem cell-derived endothelial cells elucidate single-cell phenotype of pulmonary veno-occlusive disease
Baihui Ma, Tianjiao Li, Wenke Li, Hang Yang, Qixian Zeng, Zihang Pan, Kai Wang, Qianlong Chen, Changming Xiong, Zhou Zhou
Stem Cell Reports. 2022;
[Pubmed]  [Google Scholar] [DOI]
7 Role of Sildenafil in Management of Pediatric Acute Respiratory Distress Syndrome
Monika Janagill, Puneet Aulakh Pooni, Siddharth Bhargava, Shibba Takkar Chhabra
Journal of Pediatric Intensive Care. 2021;
[Pubmed]  [Google Scholar] [DOI]
8 The Efficacy and Safety of Pulmonary Vasodilators in Pediatric Pulmonary Hypertension (PH): A Systematic Review and Meta-analysis
Tingting Shu, Huaqiao Chen, Lu Wang, Wuwan Wang, Panpan Feng, Rui Xiang, Li Wen, Wei Huang
Frontiers in Pharmacology. 2021; 12
[Pubmed]  [Google Scholar] [DOI]
9 Pulmonary Arterial Hypertension in Indonesia: Current Status and Local Application of International Guidelines
Lucia Kris Dinarti, Dyah Wulan Anggrahini, Oktavia Lilyasari, Bambang Budi Siswanto, Anggoro Budi Hartopo
Global Heart. 2021; 16(1)
[Pubmed]  [Google Scholar] [DOI]
10 Should sildenafil be started 2 weeks before the operation in ventricular septal defect patients with high pulmonary vascular resistance?
Ruchit Patel, Vinay Upadhyay, Vidur Bansal
Journal of Cardiac Surgery. 2021; 36(1): 422
[Pubmed]  [Google Scholar] [DOI]
11 In the child with pulmonary hypertension, does treatment with enteral sildenafil compared with a slow wean from nitric oxide alone prevent rebound pulmonary hypertension and allow for discontinuation of nitric oxide?
Seana Molloy, Steven McVea, Andrew Thompson, Thomas Bourke
Archives of Disease in Childhood. 2020; 105(4): 410
[Pubmed]  [Google Scholar] [DOI]
12 Orphan Formulations for Pediatric Use: Development and Stability Control of Two Sildenafil Citrate Solutions for the Treatment of Pulmonary Hypertension
Mauro Morri, Cecilia Casabonne, Darío Leonardi, Silvana Vignaduzzo
AAPS PharmSciTech. 2020; 21(6)
[Pubmed]  [Google Scholar] [DOI]
13 Preparation and characterization of electrospun fibrous scaffolds of either PVA or PVP for fast release of sildenafil citrate
Erick José Torres-Martínez, Ricardo Vera-Graziano, José Manuel Cervantes-Uc, Nina Bogdanchikova, Amelia Olivas-Sarabia, Ricardo Valdez-Castro, Aracely Serrano-Medina, Ana Leticia Iglesias, Graciela Lizeth Pérez-González, José Manuel Cornejo-Bravo, Luis Jesús Villarreal-Gómez
e-Polymers. 2020; 20(1): 746
[Pubmed]  [Google Scholar] [DOI]
14 Benefits of perioperative sildenafil therapy in children with a ventricular septal defect with pulmonary artery hypertension on early surgical outcomes
Ruchit Patel, Shyam Kumar Singh Thingnam, Anand Kumar Mishra, Manoj Kumar Rohit, Vinay Upadhyay, Vikram Halder, Vidur Bansal
Journal of Cardiac Surgery. 2020; 35(12): 3302
[Pubmed]  [Google Scholar] [DOI]
15 A Randomized Study of Safety and Efficacy of Two Doses of Ambrisentan to Treat Pulmonary Arterial Hypertension in Pediatric Patients Aged 8 Years up to 18 Years
Dunbar Ivy, Maurice Beghetti, Ernesto Juaneda-Simian, Diane Miller, Mary Ann Lukas, Chris Ioannou, Malek Okour, Jun Narita, Rolf M.F. Berger
The Journal of Pediatrics: X. 2020; 5: 100055
[Pubmed]  [Google Scholar] [DOI]

 

Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow